Directory Organotropona funds Cardiovascular funds Angioprotectora editorial and circulation Aurobin
This page is translated automatically with a help of Google Translate

Aurobin

See also Non appropriated

Roman name

Aurobin

The composition and the form of

Ointment-1 tubaprednizolona capronat-40 mglidokaina hydrochloride-40 Mgd-pantenol-40 mgtriclozan mazeva in the 20-megawatt tubes to 20 g; In a box one dose.

Pharmacokinetics

The farmakokinetike Aurobin drug is not available.

Indications

Apart rear passage, eczema and dermatitis vulvar of different etiology, gemorroy, fistula rear passage anopapillit.

Contraindications

Hypersensitivity, viral, Fungus and bacterial infection Pre disease and skin cancer.

Side-Effects

Leaving the application may atrophy (thinning) skin gipertrihoz (excess of hair covers are proper age and sex). When treating domestic gemorroidalnah nodes in the case of an overdose nevarajennaya aetiology (ischemia pulse).

Specific guidance

In the case of materials for a broad surface for a long time to be mindful of the rezorbtion system in the bloodstream active substances preparation.

Patient interaction

The medication with drug Aurobin lacking.

Overdosing

The drug overdose Aurobin lacking.

Dosing and Administration

External cause of depressed area thin layer of wax 2-4 times daily, after a decrease of symptoms - 1-2 times a day; In internal nodes gemorroidalnah few ointments give rectum.

Storage conditions

List B. At temperatures below 15 ° C

Shelf life

2

The registration

014951/01-2003

Of drugs

Decreases permeability and increased vascular tone wall of the rectum.

Indications for use

Inflammatory processes promejnostna area (for example, feature a rear passage eczema / neiroallergicescoe skin disease characterized moknushim, zudyashim inflammation / and dermatitis / skin inflammation / perineum, gemorroidale nodes / expansion and push veins of the rectum / cracks rear passage).

Form of

Ointment in the box on the 1920 Composition : 0.04 g kapronata PREDNISOLONE 0.4 g lidocaine hydrochloride, 0.4 g-pantenola and 0.02 g triclozana.

All products of this group